Evaluation of morbidity among human T lymphotropic virus type I carriers in Miyazaki, Japan

Journal of Infectious Diseases

Volumn 173, Issue 3, 1996, Pages 584-591

  Stuver, Sherri O ^a   Tachibana, Nobuyoshi ^b   Okayama, Akihiko ^c   Mueller, Nancy E ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Oita Prefectural Institute of Health and Environment   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; DISEASE ASSOCIATION; ENDEMIC DISEASE; FEMALE; HEART DISEASE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; JAPAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RETROVIRUS INFECTION; VIRUS CARRIER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ASTHMA; CARRIER STATE; COHORT STUDIES; DELTARETROVIRUS INFECTIONS; DIABETES COMPLICATIONS; FEMALE; HEART DISEASES; HTLV-I ANTIBODIES; HUMANS; JAPAN; KIDNEY DISEASES; MALE; MIDDLE AGED; MORBIDITY; RISK FACTORS; ULCER;

EID: 0030065791     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.3.584     Document Type: Article

References (13)

1. Hinuma Y, Komoda H, Chosa T, et al. Antibodies to adult T-cell leukemia virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer 1982;29:631-5.
2. Maeda Y, Furukawa M, Takehara Y, et al. Prevalence of possible adult T-cell leukemia virus carriers among volunteer blood donors in Japan: a nation-wide study. Int J Cancer 1984;33:717-20.
3. Miller GJ, Pegram SM, Kirkwood BR, et al. Ethnic composition, age, and sex together with location and standard of housing as determinants of HTLV-I infection in an urban Trinidadian community. Int J Cancer 1986; 38:801-8.
4. Murphy EL, Figueroa JP, Gibbs WN, et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991; 133:1114-24.
5. Hunsmann G, Bayer H, Schneider J, et al. Antibodies to ATLV/HTLV-1 in Africa. Med Microbiol Immunol 1984; 173:167-70.
6. Delaporte E, Peeters M, Durand JP, et al. Seroepidemiological survey of HTLV-I infection among randomized populations in western central African countries. J Acquir Immune Defic Syndr 1989;2:410-3.
7. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984; 81:2534-7.
8. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
9. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity [letter]. Lancet 1986; 1:1031-2.
10. Tajima K, T-and B-cell Malignancy Study Group. The fourth nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. Int J Cancer 1990;45:237-43.
11. Tajima K, Hinuma Y. Epidemiological features of adult T-cell leukemia virus. In: Mathe G, Reizenstein P, eds. Pathophysiological aspects of cancer epidemiology. Oxford: Pergamon Press, 1984:75-87.
12. Murphy EL, Hanchard B, Figueroa JP, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989;43:250-3.
13. Mueller N. The epidemiology of HTLV-I infection. Cancer Causes Control 1991;2:37-52.